Vishal Patel, MD
Dermatology · Leesburg, VANPI 1447410246
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 36.5% of the total. 2025 is the largest year on record at $253,234, 4.4 times the $58,110 reported in 2019. Among dermatology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 755 payments — averaging $952.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$262K
- Regeneron$169K
- Sanofi$132K
- Sun Pharmaceutical Industries Inc.$112K
- Almirall LLC$35K
- Biofrontera Inc.$3K
- plus $5K from 29 others
Across 179 payments — averaging $2232.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$390K
- Merck$10K
What the payments were for
- Consulting fees$286,90940%
- Speaking & faculty fees$342,17348%
- Travel & lodging$74,74310%
- Food & beverage$14,9362%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 210 | $262,204 |
| Regeneron | 138 | $169,405 |
| Sanofi | 99 | $132,039 |
| Sun Pharmaceutical Industries Inc. | 104 | $112,007 |
| Almirall LLC | 25 | $35,030 |
| Biofrontera Inc. | 8 | $2,973 |
| AbbVie | 42 | $867 |
| Dr.reddy's Laboratories,inc. | 1 | $725 |
| Novartis | 32 | $717 |
| Incyte Corporation | 19 | $420 |
| Abbott | 6 | $401 |
| Lilly USA, LLC | 13 | $300 |
| Kerecis Limited | 6 | $282 |
| Amgen | 8 | $240 |
| Verrica Pharmaceuticals Inc. | 2 | $220 |
| Boehringer Ingelheim | 6 | $167 |
| LEO Pharma Inc. | 3 | $122 |
| Johnson & Johnson | 7 | $115 |
| UCB, Inc. | 5 | $98 |
| Merck | 3 | $76 |
| Galderma Laboratories, L.p. | 2 | $49 |
| Springworks Therapeutics, Inc. | 2 | $35 |
| Kyowa Kirin, Inc. | 2 | $33 |
| Biocon Biologics Inc | 1 | $30 |
| Arcutis Biotherapeutics, Inc. | 1 | $24 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $23 |
| Tempus AI, Inc | 1 | $23 |
| AstraZeneca | 1 | $22 |
| Organon | 1 | $21 |
| Organogenesis Inc. | 1 | $18 |
| Dermira, Inc. | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $13 |
| Array Biopharma Inc | 1 | $13 |
| Biowound Solutions, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LIBTAYO$557,706
- ODOMZO$85,225
- Klisyri$28,993
- Unloxcyt$15,475
- Seysara$11,968
- LEVULAN KERASTICK$9,034
- AMELUZ$2,765
- BF-RhodoLED$2,765
- XEPI$1,640
- RhodoLED XL$1,125
- Kerecis SurgiClose$650
- Kerecis GraftGuide$162
- YCANTH$160
- ENSITE PRECISION$109
- CARDIOMEMS$102
How this compares
$718,760 in reported general payments places this provider in the 95th percentile of 396 dermatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 20 | $93 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Leesburg
- Naiem IssaVienna$2M
- Saurabh SinghFairfax$1.7M
- Diego DasilvaVirginia Beach$1.1M
- Cyndi Torosky TommasoVirginia Beach$717K
- Daniel HurdBlacksburg$545K
- Jonathan SchreiberNorfolk$330K
- Robert BaerSuffolk$303K
- David PariserNorfolk$261K
- Hema SundaramFairfax$181K
- Abrahem KazemiCentreville$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.